U.S. Markets open in 2 hrs 34 mins

Top Ranked Momentum Stocks to Buy for November 22nd

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 22nd:

Garmin Ltd. (GRMN): This company that designs, develops, manufactures, markets, and distributes a range of navigation, communication, and information devices has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.

Garmin Ltd. Price and Consensus

Garmin Ltd. Price and Consensus

Garmin Ltd. price-consensus-chart | Garmin Ltd. Quote

Garmin’s shares gained 12.2% over the last one month above the S&P 500’s increase 3.6%. The company possesses a Momentum Score of A.

Garmin Ltd. Price

Garmin Ltd. Price

Garmin Ltd. price | Garmin Ltd. Quote

Ultra Clean Holdings, Inc. (UCTT): This company that designs, develops, prototypes, engineers, manufactures, and tests production tools, modules, and subsystems for the semiconductor and display capital equipment industries has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 13% over the last 60 days.

Ultra Clean Holdings, Inc. Price and Consensus

Ultra Clean Holdings, Inc. Price and Consensus

Ultra Clean Holdings, Inc. price-consensus-chart | Ultra Clean Holdings, Inc. Quote

Ultra Clean Holdings’ shares gained 33.6% over the last one month. The company possesses a Momentum Score of A.

Ultra Clean Holdings, Inc. Price

Ultra Clean Holdings, Inc. Price

Ultra Clean Holdings, Inc. price | Ultra Clean Holdings, Inc. Quote

Amedisys, Inc. (AMED): This company provides healthcare services has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.

Amedisys, Inc. Price and Consensus

Amedisys, Inc. Price and Consensus

Amedisys, Inc. price-consensus-chart | Amedisys, Inc. Quote

Amedisys’ shares gained 16.9% over the last one month. The company possesses a Momentum Score of A.

Amedisys, Inc. Price

Amedisys, Inc. Price

Amedisys, Inc. price | Amedisys, Inc. Quote

DaVita Inc. (DVA): This company that provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.6% over the last 60 days.

DaVita Inc. Price and Consensus

DaVita Inc. Price and Consensus

DaVita Inc. price-consensus-chart | DaVita Inc. Quote

DaVita’s shares gained 21.8% over the last one month. The company possesses a Momentum Score of A.

DaVita Inc. Price

DaVita Inc. Price

DaVita Inc. price | DaVita Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

The Hottest Tech Mega-Trend of All                

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Ultra Clean Holdings, Inc. (UCTT) : Free Stock Analysis Report
 
Garmin Ltd. (GRMN) : Free Stock Analysis Report
 
DaVita Inc. (DVA) : Free Stock Analysis Report
 
Amedisys, Inc. (AMED) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research